Mercier Johanna: insider trades.
Mercier Johanna reported 10 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($4.7M), across 1 company.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 6
- Companies
- 1
- Name as filed
- Mercier Johanna
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Gilead Sciences, Inc. (GILD) | Officer · Chief Comm & Corp Aff Officer | 10 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Gilead Sciences, Inc. | S | 1,600 | $143.69 | 118,084 | Form 4 |
| 2026-09-15 | Gilead Sciences, Inc. | S | 800 | $144.46 | 117,284 | Form 4 |
| 2026-09-15 | Gilead Sciences, Inc. | S | 600 | $145.29 | 116,684 | Form 4 |
| 2026-09-10 | Gilead Sciences, Inc. | M | 2,797 | — | 121,031 | Form 4 |
| 2026-09-10 | Gilead Sciences, Inc. | F | 1,347 | $144.81 | 119,684 | Form 4 |
| 2026-08-17 | Gilead Sciences, Inc. | S | 11,470 | $138.04 | 118,234 | Form 4 |
| 2026-08-17 | Gilead Sciences, Inc. | S | 16,530 | $137.37 | 129,704 | Form 4 |
| 2026-08-17 | Gilead Sciences, Inc. | M | 1,890 | $72.34 | 146,234 | Form 4 |
| 2026-08-17 | Gilead Sciences, Inc. | M | 23,110 | $66.64 | 144,344 | Form 4 |
| 2026-07-15 | Gilead Sciences, Inc. | S | 3,000 | $129.92 | 121,234 | Form 4 |
Questions
What stock did Mercier Johanna buy or sell?
Mercier Johanna reported 10 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($4.7M), across 1 company.
Is Mercier Johanna the same person as other filers with this name?
This page covers SEC CIK 1782135 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/mercier-johanna-1782135.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.